Skip to content

A prospective, multicentre, cluster randomised controlled trial to evaluate the impact of the implementation of COPD quality standards in high exacerbation risk patients: A COPD Quality Improvement Program (QIP)

A prospective, multicentre, cluster randomised controlled trial to evaluate the impact of the implementation of COPD quality standards in high exacerbation risk patients: A COPD Quality Improvement Program (QIP)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064644
Enrollment
Unknown
Registered
2022-10-13
Start date
2022-10-13
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Intervention group:Standard of practice for clinical diagnosis and treatment of Chronic Obstructive Pulmonary Disease
Control group:Maintain current treatment

Sponsors

Shenzhen People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed with COPD; 2. Aged 40 years or older; 3. CAT >=10; 4. With exacerbation history: at least 2 moderate or 1 severe exacerbation in the previous year;or 1 moderate exacerbation in the previous year with FEV1 <50% predicted value at baseline; 5. Must be able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients on triple therapy at baseline with a LAMA, LABA, and inhaled corticosteroid (ICS) combination (Including open triple and fix-dose triple); 2. Significant diseases or conditions other than COPD, which, in the opinion of the Investigator, may put the subject at risk because of participation in the study or may influence either the results of the study or the subjects ability to participate in the study; 3. Patients who are currently involved in any other interventional studies.

Design outcomes

Primary

MeasureTime frame
Pulmonary function test;Chronic obstructive pulmonary disease assessment test (CAT);

Countries

China

Contacts

Public ContactRongchang Chen

Shenzhen People’s Hospital

chenrc@vip.163.com+86 13902273260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026